59 F
Fort Worth
Saturday, October 24, 2020
Banking Stocks rise broadly after Trump postpones tariff increase

Stocks rise broadly after Trump postpones tariff increase

Other News

Exxon’s oil slick

Exxon Mobil is slashing its capital spending budget for 2020 by 30% due to weak demand caused by the COVID-19 pandemic and a market...

Folk music’s Mark Twain: 7 Essential tracks from John Prine,

NEW YORK (AP) — Some people, the songs just come out of them. For nearly half a century, they tumbled out of John Prine...

Tarrant County records another COVID-19 death

Tarrant County Public Health (TCPH) on Wednesday, April 8 reported that a resident of Euless has died as the result of the COVID-19 virus....

Tradition stymied: A year unlike any since WWII for Augusta

The Masters is so intertwined with Augusta, they added an extra day to spring break.You see, the first full week of April isn't just...

NEW YORK (AP) — Stocks moved broadly higher on Wall Street after President Donald Trump agreed to hold off on raising tariffs on Chinese goods, which would have escalated a damaging trade war between the world’s two largest economies.

Investors had been growing increasingly optimistic over the last two weeks that the U.S. and China were moving closer to a resolution in the trade tiff. The fight is over U.S. complaints that Beijing steals or pressures companies to hand over technology.

Information technology and industrial companies led the gains. Consumer goods and utility companies lagged the overall market.

The nations faced a March 1 deadline that would have increased punitive duties on $200 billion in Chinese imports. Trump did not set a new deadline. He said there had been “productive talks” on some of the more difficult issues and he’s willing to meet with Chinese President Xi Jinping if negotiations progress.

The trade war and its hefty tariffs have already raised prices and costs for businesses and consumers. Any additional escalation could shake investor confidence as an economic slowdown looms over China and Europe.

Elsewhere, oil prices fell after Trump said they were getting too high. Industrial giant General Electric rose after it announced plans to sell a biotech unit. Spark Therapeutics doubled after pharmaceutical giant Roche offered to buy the gene therapy developer.

The gains come as investors have a full schedule of economic and corporate news to consider this week.

Retailers, including Macy’s, will report their latest financial results this week. The Commerce Department will release fourth-quarter gross domestic product on Thursday and Federal Reserve Chairman Jerome Powell is scheduled for two days of Congressional testimony this week.

ANALYST’S TAKE: “I feel like we’re in a position where the president is interested in making deals,” said Jamie Cox, managing partner at Harris Financial Group.

The U.S. election cycle is just around the corner, giving the president incentive to pursue deals and keep the economy and markets stable, he said. But, markets may be overoptimistic on what’s possible in any China deal. Any negotiations over intellectual property concerns will like take more time.

Investors still need to remain cautious, Cox said, citing soft economic data, including the surprise drop in retail sales in December.

“This is sort of an economic opportunity for investors to rebalance to get a little less aggressive in their portfolios,” he said.

KEEPING SCORE: The Dow Jones Industrial average rose 167 points, or 0.6 percent, to 26,198 as of 12:23 p.m. Eastern time. The S&P 500 index 0.6 percent and the Nasdaq composite 0.9 percent.

OVERSEAS: China’s main index, The Shanghai Composite, jumped to an eight-month high. Progress with U.S.-China trade talks helped lift markets broadly in Asia and Europe.

GE SHEDS WEIGHT: General Electric is selling its biopharma business to Danaher for $21.4 billion. The sale is yet another step for GE to become smaller. The stock surged 12.7 percent.

GE has been divesting businesses since getting hurt in the financial crisis a decade ago. It slashed its dividend in October along with ousting CEO John Flannery. It also plans to downsize its Boston headquarters.

SPARKS: Spark Therapeutics doubled in value after pharmaceutical giant Roche offered to by the gene therapy company for about $4.8 billion.

Roche is snapping up the company as the industry as its rivals also look to gene therapy as a way to build up their potential drug pipelines. The focus is treatment for rare diseases, which often involves very costly drugs.

ENERGY: Trump criticized the rising price of oil in an early morning tweet, sending prices lower. U.S. crude lost 1.6 percent to $56.34 per barrel in New York. Prices are up 23 percent so far this year.

Brent crude, used to price international oils, fell 1.8 percent to $65.92 per barrel in London.

Latest News

Texas’ massive early voting numbers have persisted, leading to predictions of overall turnout unseen in years

By Alex Samuels and Mandi Cai, The Texas Tribune Oct. 23, 2020 "Texas’ massive early voting numbers have persisted,...

Southside Bancshares: 3Q Earnings Snapshot

TYLER, Texas (AP) _ Southside Bancshares Inc. (SBSI) on Friday reported third-quarter net income of $27.1 million.The Tyler, Texas-based bank said it...

AP FACT CHECK: Examining claims from last Trump-Biden debate

WASHINGTON (AP) — President Donald Trump and Democratic challenger Joe Biden sparred Thursday in their final presidential debate, hoping to sway undecided...

Texans John Cornyn and Ted Cruz vote to advance Amy Coney Barrett’s Supreme Court nomination to the full Senate

By Kelsey Carolan, The Texas Tribune Oct. 22, 2020 "Texans John Cornyn and Ted...

Bank OZK: 3Q Earnings Snapshot

LITTLE ROCK, Ark. (AP) _ Bank OZK (OZK) on Thursday reported third-quarter earnings of $109.3 million.The Little Rock, Arkansas-based bank that has...